Low Vitamin D Triples Pain Risk After Breast Cancer Surgery Study Finds
Women deficient in vitamin D needed far more opioids after mastectomy, suggesting a simple supplement could ease surgical recovery.
Summary
A new study found that breast cancer patients with low vitamin D levels experienced significantly more pain after mastectomy surgery. Those deficient in vitamin D were three times more likely to report moderate to severe pain in the 24 hours post-surgery and used an average of 112mg more tramadol than patients with adequate levels. Researchers believe vitamin D helps regulate pain through its anti-inflammatory effects and immune system interactions. The findings, published in Regional Anesthesia and Pain Medicine, suggest that checking and correcting vitamin D deficiency before surgery could be a straightforward strategy to improve recovery outcomes and reduce reliance on opioid medications.
Detailed Summary
Vitamin D is widely known for its role in bone health and immune function, but a new study suggests it may also significantly influence how much pain patients experience after major surgery. For the millions of women undergoing breast cancer surgery each year, this connection could have meaningful implications for recovery quality and opioid use.
Researchers at Fayoum University Hospital in Egypt conducted a prospective observational study involving 184 women scheduled for radical mastectomy. Half had vitamin D deficiency, defined as levels below 30 nmol/L, while the other half had sufficient levels. Both groups received identical standard care before, during, and after surgery, including fentanyl during the procedure and patient-controlled tramadol afterward.
The results were striking. Patients with low vitamin D were three times more likely to experience moderate to severe pain in the 24 hours following surgery. They also required an average of 8 micrograms more fentanyl intraoperatively and used 112mg more tramadol post-surgery. Since opioids carry risks including nausea, vomiting, sedation, and dependence, reducing their use through nutritional optimization represents a meaningful clinical opportunity.
The researchers propose that vitamin D modulates pain perception through its anti-inflammatory properties and its role in immune signaling. Vitamin D receptors are found throughout the nervous system, and deficiency may heighten central and peripheral pain sensitivity. Notably, vitamin D deficiency is disproportionately common in people with breast cancer, making this a particularly relevant population to screen and treat.
While the findings are compelling, this was an observational study conducted at a single center, meaning causality cannot be confirmed. Supplementation trials are needed to verify whether correcting deficiency before surgery actually reduces pain outcomes. Still, given vitamin D's low cost and favorable safety profile, pre-surgical screening appears a reasonable and low-risk clinical consideration.
Key Findings
- Vitamin D deficient patients were 3x more likely to experience moderate to severe post-mastectomy pain.
- Low vitamin D patients used 112mg more tramadol on average in the 24 hours after surgery.
- Vitamin D may regulate pain sensitivity through anti-inflammatory and immune system pathways.
- Deficiency threshold in the study was below 30 nmol/L, a commonly used clinical benchmark.
- Pre-surgical vitamin D supplementation could reduce opioid dependence during cancer surgery recovery.
Methodology
This is a news summary of a prospective observational study published in Regional Anesthesia and Pain Medicine, a peer-reviewed BMJ Group journal. The study enrolled 184 patients at a single hospital in Egypt between September 2024 and April 2025. Evidence is observational, so causation cannot be established without randomized controlled trials.
Study Limitations
The study was conducted at a single center in Egypt, which may limit generalizability to other populations and healthcare settings. As an observational design, it cannot confirm that low vitamin D causes increased pain rather than being a correlated marker. A randomized controlled trial of pre-surgical supplementation is needed to confirm clinical benefit before formal recommendations can be made.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.